This report takes a closer look at QuidelOrtho Corp. (QDEL). The company is navigating a shift in its revenue mix, with COVID-19 testing declining but core diagnostic segments showing resilience. Recent FDA clearance for its cardiac assay adds a new catalyst to watch as investors assess its financial guidance and market performance.
Recent Developments
For comments and feedback contact: editorial@rttnews.com
April 10, 2026 16:21 ET Inflation data from the U.S. was the main data event this week as the conflict in the Middle East continue. The minutes of the latest Fed policy session and the survey data on the services sector also made headlines. In Europe, manufacturing orders data from Germany was in focus. Price data from China drew attention in Asia.